Table 1.
Basic characteristics of included studies.
| Author | Year | Region | Size | Source department | Male | Test method | Sensitive | Specificity | TP | PF | FN | TN | Cut-point (pg/mL) | AUC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Duman | 2018 | Turkey | 88 | ICU | 60.0% | ELISA | 97.80% | 73.80% | 45 | 11 | 1 | 31 | 125.19 | 0.808 |
| Gao | 2023 | China | 120 | ED | 53.8% | Quantibody®Human Inflammation Array 1 | 74.76% | 74.95% | 60 | 10 | 20 | 30 | NA | 0.765 |
| Jekarl | 2019 | Korea | 160 | ICU | 55.0% | 45-Plex Human ProcartaPlex Panel 1 | 67.50% | 93.00% | 54 | 6 | 26 | 74 | 105.5 | 0.84 |
| Wang | 2018 | China | 72 | Traumatic department | 71.8% | ELISA | 92.86% | 43.75% | 36 | 19 | 3 | 14 | 240.7 | 0.82 |
| Xu | 2022 | China | 80 | RICU | 52.5% | ELISA | 97.50% | 100.00% | 39 | 0 | 1 | 40 | 14.28 | 0.996 |
| Li | 2022 | China | 168 | NA | 50.6% | ELISA | 75.00% | 85.71% | 84 | 8 | 28 | 48 | 20 | 0.825 |
| Pyle | 2011 | America | 63 | ICU | NA | ELISA | 65.00% | 76.00% | 17 | 9 | 9 | 28 | 642 | 0.7 |
| Tian | 2019 | China | 51 | ICU | 62.7% | Luminex Multiplex Assay | 69.23% | 70.59% | 18 | 7 | 8 | 18 | 382 | 0.716 |